Clinical trials
Observational Stomach Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2006 | 2 |
| 2008 | 2 |
| 2010 | 8 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 3 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Unknown status | 23 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 12 |
| Seoul National University Bundang Hospital | 9 |
| Asan Medical Center | 5 |
| Samsung Medical Center | 5 |
| Seoul National University Hospital | 4 |
| National Cancer Center, Korea | 3 |
| Novomics. Co., Ltd. | 3 |
| Saint Vincent's Hospital, Korea | 3 |
| Soonchunhyang University Hospital | 3 |
| Ajou University School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 66 |
| Gastritis, Atrophic | 5 |
| Esophageal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.